Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford scientists build a connected, ‘multi-organoid’ platform that recreates immune recruitment to the heart, opening new avenues to probe disease and test therapies.

AI-generated image of a glowing heart surrounded by medical alerts. © Adobe Stock

In a study published in Circulation Research, researchers at the Radcliffe Department of Medicine have developed a lab-grown human model that can capture how immune cells respond to heart injury in a dish – a major breakthrough in studying cardiac disease and repair.

Immune cells play a key role in cardiac injury and repair, shaping patient outcomes following heart attacks and other cardiac conditions. However, there are currently no human experimental models that can emulate those interactions in a dish. Unlike other organs, the human heart doesn’t regenerate, so patient biopsies can’t be used to provide relevant tissue to study. While immune cells can be taken from donor blood and added to engineered cardiac models, this approach is artificial, variable and difficult to scale. This has been a major roadblock in developing therapies and investigating the mechanisms that underpin cardiac injury and repair.

In this new study, researchers created a multi-organoid system by linking together human bone marrow and heart organoids – miniature, lab-grown versions of human organs derived from induced pluripotent stem cells.

The organoids were connected using a 3D-printed device, which allowed cells and fluid to move between them. When the heart organoid was subjected to injury, immune cells from the bone marrow organoid were recruited into the damaged tissue – mimicking, for the first time in a dish, the complex immune response to heart injury.

 

Read the full story on the Radcliffe Department of Medicine website.

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience